Search clinical trials for: Relapsed/Refractory NHL

Total 4905 results

Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation

Multiple Myeloma | Hodgkin's Lymphoma | AML | Hematologic Malignancy | NHL | CML | ALL

United States
University of Giessen

Completed

Bendamustine Plus Rituximab Versus CHOP Plus Rituximab

Marginal Zone Lymphomas | Non-Hodgkin Lymphomas | Follicular Lymphomas | Immunocytomas | Lymphocytic Lymphomas

Germany
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Weight Loss Maintenance (WLM) (WLM)

Heart Diseases | Cardiovascular Diseases | Hypertension | Obesity | Diabetes Mellitus, Non-insulin Dependent
University of Michigan
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes

Sleep Apnea Syndromes

United States
University of Michigan
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Sleep and Behavior in Children With Cleft Palate

Cleft Palate

United States
Washington University School of Medicine
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Evaluating a Blood Pressure Reduction and Weight Loss Program in a Low Income, Ethnically Diverse Population (The Be Fit, Be Well [BFBW] Study) (BFBW)

Hypertension | Obesity

United States
Fred Hutchinson Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Blood Samples to Evaluate Biomarkers of Donor Chimerism

Leukemia | Myelodysplastic Syndrome | Hodgkins Disease | Non-hodgkins Lymphoma

United States
CW Optics, Inc.
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Optical Detection of Intravenous Infiltration

Extravasation of Diagnostic and Therapeutic Materials | Intravenous Infiltration

United States
Fernando Cabanillas
Genzyme, a Sanofi Company

Completed

Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL (CHOP-R)

Lymphoma | Non Hodgkin's Lymphoma

Puerto Rico
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Neighborhood SES on Coronary Heart Disease Burden in Communities - Ancillary to ARIC

Heart Diseases | Cardiovascular Diseases | Coronary Disease
University of Vermont
University of California, San Diego; National Heart, Lung, and Blood Institute...

Completed

Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome

Venous Thrombosis | Venous Insufficiency

United States
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

Endothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESA (MESA-LUNG)

Emphysema | Endothelial Dysfunction | Chronic Obstructive Pulmonary Disease (COPD)
University of California, Los Angeles
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican Individuals

Coronary Disease | Hyperlipidemia, Familial Combined

Mexico
Hartford Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Effect of Statin Medications on Muscle Performance (The STOMP Study) (STOMP)

Muscular Diseases | Hydroxymethylglutaryl-CoA Reductase Inhibitors

United States
San Diego State University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Socioeconomic Status, Psychosocial Factors, and CVD Risk in Mexican-American Women

Hypertension | Cardiovascular Disease | Metabolic Disorders

United States
University of Washington
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event

Rhabdomyolysis

United States
King Faisal Specialist Hospital & Research Center

Unknown

Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases

Lymphoma, Non-Hodgkin | Hodgkin Disease

Saudi Arabia
King Faisal Specialist Hospital & Research Center

Unknown

Functional Assessment of Cancer Therapy - Bone Marrow Transplant (FACT-BMT)

Lymphoma, Non-Hodgkin | Hodgkin Disease

Saudi Arabia
Icahn School of Medicine at Mount Sinai
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices

Congestive Heart Failure

United States
Bayer

Completed

Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan (ZEVALIN-SDUI)

Non-Hodgkin's Lymphoma (NHL)

Japan
Genentech, Inc.
Amgen

Terminated

A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas

Non-Hodgkin's Lymphoma
Hospital for Special Surgery, New York

Completed

A Randomized Trial to Improve Quality of Life Outcomes in Asthma Patients

Asthma

United States
MedImmune LLC

Terminated

A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)

Lymphoma

United States, Poland
Clarassance, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)

Bronchopulmonary Dysplasia | Respiratory Distress Syndrome in Premature Infant

United States
Icahn School of Medicine at Mount Sinai
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Epidemiology of Ventricular Assist Device-Related Infections

Congestive Heart Failure

United States
HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI); Thalassemia Clinical Research...

Completed

Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study

Thalassemia

United States, Canada, United Kingdom
M.D. Anderson Cancer Center
Biogen

Completed

Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma

Lymphoma, Mantle-Cell

United States
Oregon Research Institute
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With Diabetes

Heart Diseases | Cardiovascular Diseases | Diabetes Mellitus, Type 2

United States
Oregon Research Institute
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Enhancing Support for Women With Type 2 Diabetes: Follow-Up

Type 2 Diabetes Mellitus

United States
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Unknown

Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma (REAL07)

Follicular Lymphoma | Non Hodgkin Lymphoma

Italy
UCSF Benioff Children's Hospital Oakland
National Heart, Lung, and Blood Institute (NHLBI); University of California... and other collaborators

Completed

Cholesterol and Pharmacogenetic Study (CAP)

Cardiovascular Disease | Hypercholesterolemia | Coronary Heart Disease | Hyperlipidemia

United States
University of Washington
National Heart, Lung, and Blood Institute (NHLBI); American Thoracic Society; American Society for Parenteral and Enteral Nutrition and other collaborators

Completed

A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)

Acute Respiratory Distress Syndrome | Acute Lung Injury | Respiratory Distress Syndrome, Adult

United States, Canada
Public Health Foundation of India
National Heart, Lung, and Blood Institute (NHLBI); All India Institute of Medical... and other collaborators

Unknown

A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South Asia (CARRS)

Hypertension | Type 2 Diabetes Mellitus | Dyslipidaemia

India, Pakistan
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity

Obesity | Growth Hormone

United States
vTv Therapeutics
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic Pathway Antagonist (IPA)

Coagulation

United States
Amgen

Completed

A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma

Cancer | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Thrombocytopenia | Oncology | Chemotherapy-Induced Thrombocytopenia
Ortho Biotech Products, L.P.

Completed

A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy

Leukemia | Anemia | Hodgkin Disease | Lymphoma, Non-hodgkin
University of Washington
National Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health... and other collaborators

Terminated

Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)

Brain Injuries, Traumatic

United States, Canada
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Terminated

Range of Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Otherwise Healthy Smokers

Healthy Smokers

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL

Lymphoma

United States
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI); Partners HealthCare, Inc.

Completed

Direct to Smoker Outreach in a Health Care Setting (DTS)

Tobacco Dependence

United States
Charite University, Berlin, Germany
Wyeth is now a wholly owned subsidiary of Pfizer; Mundipharma K.K.

Withdrawn

Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)

Mantle Cell Lymphoma

Germany
Roswell Park Cancer Institute
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

Lymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic-Myeloproliferative Diseases

United States
University of Washington
National Heart, Lung, and Blood Institute (NHLBI); National Institute of Neurological... and other collaborators

Terminated

Hypertonic Resuscitation Following Traumatic Injury

Shock, Traumatic

United States, Canada
BioMarck Pharmaceuticals, Ltd.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD (BREATH-1)

Chronic Obstructive Pulmonary Disease | COPD

United States
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Comparison of Two Workplace-Sponsored Obesity Prevention Programs

Weight Loss
AstraZeneca

Terminated

Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies

Lymphoma

United States, Canada
Biogen

Terminated

Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin's

United States
Inje University

Unknown

BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)

Non Hodgkin's Lymphoma

Korea, Republic of
Memorial Hospital of Rhode Island
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Translating ATP III Cholesterol Management Guidelines Into Primary Care Practice

Coronary Disease | Hypercholesterolemia | Primary Health Care | Management, Risk

United States

Search clinical trials for: Relapsed/Refractory NHL

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations